Drug Reimportation is Bad Policy Medicine In a clear example of the “cure being worse than the disease,” the House of Representatives recently passed legislation that gives the impression members believe that cheap prescription drugs are more important than safe drugs and that cheap drugs today are more important than new drugs tomorrow. Just before leaving for the August recess, the House approved by a vote of 243 to 186 the Pharmaceutical Market Access Act of 2003--a bill that allows consumers to import prescription drugs from 26 countries, including Canada and Europe. The lawmakers rejected a more sweeping proposal that...